FDA
-
-
-
-
-
-
-
Pfenex (PFNX) Announces Positive European CHMP Opinion for PF708 and New Partnership in Latin America, and Provides CRM197 Business Update
-
-
-
-
-
-
-
Pfenex to Present at the Piper Jaffray 31st Annual Healthcare Conference
-
-
-
-
-
-
-
Pfenex Provides Update for PF708 Outside the United States
-
-
-
-
-
-
-
Pfenex Reports First Quarter 2019 Results and Provides Business Update
-
-
-
-
-
-
-
Pfenex Announces FDA Acceptance of NDA for PF708
-
-
-
-
-
-
-
Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)
-
-
-
-
-
-
-
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

